Dopamine receptors in hypertension

Mount Sinai Journal of Medicine

Volumn 68, Issue 6, 2001, Pages 362-369

  Bek, M J ^a   Eisner, G M ^a   Felder, R A ^a   Jose, P A ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dopamine; Dopamine receptor; Hypertension; Sodium transport; Transgenic mice

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALDOSTERONE; DOMPERIDONE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR; RECEPTOR SUBTYPE; RENIN; VASOPRESSIN;

ALDOSTERONE RELEASE; ARTICLE; AUTOCRINE EFFECT; AWARENESS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR FUNCTION; CENTRAL NERVOUS SYSTEM; COMPREHENSION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ELECTROLYTE BALANCE; ESSENTIAL HYPERTENSION; EVIDENCE BASED MEDICINE; FLUID BALANCE; KIDNEY FUNCTION; NONHUMAN; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; PHYSIOLOGY; RAT; REGULATORY MECHANISM; RENIN RELEASE; SIGNAL TRANSDUCTION; SODIUM URINE LEVEL; VASOPRESSIN RELEASE;

BLOOD PRESSURE; HUMANS; HYPERTENSION; RECEPTORS, DOPAMINE;

EID: 0034755534     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (88)

1. The renal dopamine receptors in health and hypertension
2. Dopaminergic mechanisms in the development of hypertension
3. Role of the mesolimbic dopamine system in cardiovascular homeostasis. Stimulation of the ventral tegmental area modulates the effect of vasopressin on blood pressure in conscious rats
4. Influence of dopaminergic mechanisms on 24-hour secretory patterns of prolactin, luteinizing hormone and testosterone in recumbent men
5. Recent progress in the control of aldosterone secretion
6. Dopamine-dependent inhibition of jejunal Na+-K+-ATPase during high-salt diet in young but not in adult rats
7. Dopamine and sodium appetite: Antagonists suppress sham drinking of NaCl solutions in the rat
8. Neurochemistry of dopaminergic nerves
9. Dopamine inhibits Na+-H+ exchanger activity in renal BBMV by stimulation of adenylate cyclase
10. Effect of renal interstitial infusion of L-DOPA on sodium and phosphate excretions
11. Does dopamine use several signal pathways to inhibit Na-Pi transport in OK cells?
12. Dopamine regulates phosphate uptake by opossum kidney cells through multiple counter-regulatory receptors
13. Dopamine inhibits renal Na+:HCO3- cotransporter in rabbits and normotensive rats but not in spontaneously hypertensive rats
14. Dopamine regulation of renal Na+, K+-ATPase activity is lacking in Dahl salt-sensitive rats
15. Renal dopamine DA1 receptor coupling with GS and Gq/11 proteins in spontaneously hypertensive rats
16. Stimulation of Na+-K+-2Cl cotransport in rat medullary thick ascending limb by dopamine
17. Bromocriptine stimulates Na+,K+-ATPase in renal proximal tubules via cAMP pathway
18. Dopamine D4 receptor isoform mRNA and protein are expressed in the rat cortical collecting duct
19. Dopaminergic inhibition of the action of vasopressin on the cortical collecting tubule
20. Dopamine antagonizes the actions of angiotensin II in renal brush-border membrane
21. Regulation of NHE-3 activity by G-protein subunits in renal brush border membranes
22. Regulation of Na-K-ATPase activity in the proximal tubule: Role of the protein kinase C pathway and of eicosanoids
23. 2 receptors
24. Altered arachidonic acid metabolism contributes to the failure of dopamine to inhibit Na+,K+-ATPase in kidney of spontaneously hypertensive rats
25. Endogenous dopamine regulates phosphate reabsorption but not Na K-ATPase in spontaneously hypertensive rat kidneys
26. Endosomal recycling of the Na+/H+ exchanger NHE3 isoform is regulated by the phosphatidylinositol 3-kinase pathway
27. Dopamine-induced endocytosis of Na+,K+-ATPase is initiated by phosphorylation of Ser-18 in the rat alpha subunit and is responsible for the decreased activity in epithelial cells
28. Effects of dopamine blockade on renal sodium excretion
29. Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule
30. Role of kidney dopamine in the natriuretic response to volume expansion in rats
31. Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats
32. The effect of dopamine receptor blockade on natriuresis is dependent on the degree of hypervolemia
33. -like receptors on renal function
34. Effects of extracellular fluid volume changes on renal response to low-dose dopamine infusion in normal women
35. Effect of dopamine and bromocriptine on rat ileal and colonic transport. Stimulation of absorption and reversal of cholera toxin-induced secretion
36. Role of renal nerves and endogenous dopamine in amino acid-induced glomerular hyperfiltration
37. Expression of the subtype 1A dopamine receptor in the rat heart
38. Dopamine stimulation of cardiac beta-adrenoceptors: The involvement of sympathetic amine transporters and the effect of SKF38393
39. Peripheral dopamine in hypertension and associated conditions
40. Effect of decreased dopamine synthesis on the development of hypertension induced by salt loading in spontaneously hypertensive rats
41. Role of renal dopamine receptor in the pathogenesis of hypertension after sodium loading
42. Dopamine-2 receptor blockade potentiates the renal effects of nitric oxide inhibition in humans
43. Renal dopamine receptors and pre- and post-cAMP mediated sodium transport defect in the spontaneously hypertensive rat
44. Organ specificity of the dopaminel receptor/adenylyl cyclase coupling defect in spontaneously hypertensive rats
45. Defective G protein activation of the cAMP pathway in rat kidney during genetic hypertension
46. Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status
47. Fenoldopam: A new dopamine agonist for the treatment of hypertensive urgencies and emergencies
48. 1A dopamine receptor in the pathogenesis of genetic hypertension
49. 1A receptor induces antinatriuresis in conscious rats
50. Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings
51. Genetic isolation of a region of chromosome 8 that exerts major effects on blood pressure and cardiac mass in the spontaneously hypertensive rat
52. Dopamine-1 receptor defect in renal proximal tubular cells in essential hypertension
53. Dopamine D1 receptor gene polymorphism is associated with essential hypertension
54. G-protein-coupled receptor kinase activity is increased in hypertension
55. G-protein-coupled receptor kinase activity in hypertension
56. Combinations of variations in multiple genes are associated with hypertension
57. Renal protein phosphatase 2A activity and spontaneous hypertension in rats
58. AVP-dependent hypertension in mice with disrupted dopamine D5 receptor
59. Non-N-methyl D-aspartate receptors are involved in the hypertension of D5 dopamine receptor knockout mice
60. Association of the - Adducin locus with essential hypertension
61. Dopaminergic control of prolactin and blood pressure: Altered control in essential hypertension
62. The nigrostriatal dopamine system: Role in the development of hypertension in spontaneously hypertensive rats
63. Brain dopamine D2 receptor mRNA levels are elevated in young spontaneously hypertensive rats
64. Modulation of blood pressure and obesity with the dopamine D2 receptor gene Taq1 polymorphism
65. Genetic isolation of a region of chromosome 8 that exerts major effects on blood pressure and cardiac mass in the spontaneously hypertensive rat
66. Disruption of the dopamine D2 receptor produces non-renal dependent hypertension
67. Dopamine D1A receptors and renin release in rat juxtaglomerular cells
68. Dopamine decreases expression of type-1 angiotensin II receptors in renal proximal tubule
69. Bromocriptine regulates angiotensin II response on sodium pump in renal proximal tubules
70. Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension
71. Dopaminergic regulation of aldosterone secretion: Its pathophysiologic significance in subsets of primary aldosteronism
72. Dopamine and non-modulating hypertension
73. Dopamine D3 receptors in rat juxtaglomerular cells
74. Early emergence of three dopamine D1 receptor subtypes in vertebrates: Molecular phylogenetic, pharmacological, and functional criteria defining D1A, D1B, and D1C receptors in European eel Anguilla anguilla
75. New insights into dopaminergic receptor function using antisense and genetically altered animals
76. Dopamine receptors: From structure to function
77. Phosphatidylinositol 3-kinase-mediated endocytosis of renal Na+, K+-ATPase alpha subunit in response to dopamine
78. The dopamine-1 agonist, SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase
79. Diminished phospholipase C activation by dopamine in spontaneously hypertensive rats
80. Inhibition of hormonally induced inositol trisphosphate production in transfected GH4C1 cells: A novel role for the D5 subtype of the dopamine receptor
81. Dual signaling regulated by calcyon, a D1 dopamine receptor interacting protein
82. Cardiovascular actions of bromocriptine: Evidence for a neurogenic mechanism
83. Stereoselectivity of S- and R-sulpiride for pre- and postsynaptic dopamine receptors in the canine kidney
84. Evidence that dopamine-2 mechanisms control renal function
85. Effect of dopamine 2 blockade on renal function under varied sodium intake
86. Human dopamine D3 receptors mediate mitogen-activated protein kinase activation via a phosphatidylinositol 3-kinase and an atypical protein kinase C-dependent mechanism
87. Dopamine D3 receptor activation modulates renal function in anesthetized rats
88. The natriuretic response to a dopamine DA1 agonist requires endogenous activation of dopamine DA2 receptors